Cargando…
Danqi Pill regulates lipid metabolism disorder induced by myocardial ischemia through FATP-CPTI pathway
BACKGROUND: Danqi Pill (DQP), which contains Chinese herbs Salvia miltiorrhiza Bunge and Panax notoginseng, is widely used in the treatment of myocardial ischemia (MI) in China. Its regulatory effects on MI-associated lipid metabolism disorders haven’t been comprehensively studied so far. We aimed t...
Autores principales: | Wang, Yong, Li, Chun, Wang, Qiyan, Shi, Tianjiao, Wang, Jing, Chen, Hui, Wu, Yan, Han, Jing, Guo, Shuzhen, Wang, Yuanyuan, Wang, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4355010/ https://www.ncbi.nlm.nih.gov/pubmed/25885422 http://dx.doi.org/10.1186/s12906-015-0548-0 |
Ejemplares similares
-
Multitarget Effects of Danqi Pill on Global Gene Expression Changes in Myocardial Ischemia
por: Wang, Qiyan, et al.
Publicado: (2018) -
Effect of DanQi Pill on PPARα, lipid disorders and arachidonic acid pathway in rat model of coronary heart disease
por: Chang, Hong, et al.
Publicado: (2016) -
DanQi Pill protects against heart failure through the arachidonic acid metabolism pathway by attenuating different cyclooxygenases and leukotrienes B4
por: Wang, Yong, et al.
Publicado: (2014) -
Danqi Pill Protects Against Heart Failure Post-Acute Myocardial Infarction via HIF-1α/PGC-1α Mediated Glucose Metabolism Pathway
por: Zhang, Qian, et al.
Publicado: (2020) -
Pro-angiogenic Role of Danqi Pill Through Activating Fatty Acids Oxidation Pathway Against Coronary Artery Disease
por: Jiao, Shihong, et al.
Publicado: (2018)